APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2019). Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie). Canadian Agency for Drugs and Technologies in Health.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Risankizumab (Skyrizi) (AbbVie). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Risankizumab (Skyrizi) (AbbVie). Canadian Agency for Drugs and Technologies in Health, 2019.

Warning: These citations may not always be 100% accurate.